Acs Fall 2025 Agenda. Explore acs fall 2025 agenda: Vividion has already disclosed work on covalent keap1 inhibitors, but at the recent acs fall 2025 meeting, the structure and discovery story of their clinical oral.
Just saw this on the acs skills. Vividion has already disclosed work on covalent keap1 inhibitors, but at the recent acs fall 2025 meeting, the structure and discovery story of their clinical oral.
